retatrutide drug test for Weight Loss: TRIUMPH-1 Results, Cost, Insurance A New Obesity Drug Delivered

The fact that GLP-1 is rapidly metabolized and its postprandial concentrations are considerably lower than GIP concentrations brings into question how much intact peptide actually reaches the pancreas

For instance, California, New Hampshire, Pennsylvania and South Carolina stopped covering GLP-1s for weight loss as of Jan

And the real question now is: Who will own the metabolic care ecosystem of the future

A BETTER WAY TO DO WEIGHT LOSS

The one area where data remains genuinely uncertain is very long-term use (10+ years), because the medications haven't been on the market that long at obesity-treatment doses